Abbott Healthcare Products Limited

Mansbridge Road, West End, Southampton, SO18 3JD
Telephone: +44 (0)2380 467 000
Fax: +44 (0)2380 465 350
Medical Information Direct Line: +44 (0)2380 467 000
Medical Information e-mail: medinfo.shl@abbott.com
Medical Information Fax: +44 (0)2380 474518

Patient Information Leaflet last updated on the eMC: 06/06/2011
PIL Lipantil Micro 200

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 17/03/2011 and displayed until 06/06/2011
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 08/02/2011 and displayed until 17/03/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change due to user-testing of patient information
Updated on 28/05/2008 and displayed until 08/02/2011
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 07/09/2007 and displayed until 28/05/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 13/07/2007 and displayed until 07/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 21/04/2006 and displayed until 13/07/2007
Reasons for adding or updating:
  • Product Acquisition
Updated on 06/07/2000 and displayed until 21/04/2006
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   fenofibrate